Several private equity firms reportedly have shown interest in pharmaceutical giant Sanofi's (SNY) consumer health unit.
According to Bloomberg, citing people familiar with the matter, buyout firms, including Advent International and Blackstone Group Inc., are seeking to invest in the consumer health division of the French pharmaceutical giant ahead of a potential separation of the business.
The business is also drawing early interest from Bain Capital, CVC Capital Partners, EQT AB and KKR & Co., according to the report. The unit could be valued at about $20 billion in any deal, they said.
Sanofi said in October that it plans to separate the division. The company had then said that separation would enable greater management focus and resource allocation to the needs of the Biopharma business, where value-creating opportunities and longer-term operational levers have been identified to support the accelerated R&D investments.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.